1 / 23

Bio-control of grain storage insect pests

Bio-control of grain storage insect pests. Registering a mycoinsecticide product for use in storage structures. Project Executive: Julie Flood Senior Users: Dick Shaw Senior Suppliers:Sean Murphy Project Manager: Bryony Taylor Date: 12 April 2010.

ejulio
Download Presentation

Bio-control of grain storage insect pests

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bio-control of grain storage insect pests Registering a mycoinsecticide product for use in storage structures. Project Executive: Julie Flood Senior Users: Dick Shaw Senior Suppliers:Sean Murphy Project Manager: Bryony Taylor Date: 12 April 2010

  2. Part A – Background (1)Executive Summary & Objectives Executive Summary. The project is to register an experimental mycoinsecticide product to control pests in stored grain. This builds on work done in two LINK projects since 2003 and is a collaboration largely between CABI and FERA and three commercial companies. The project is led by Exosect Ltd • Project Objectives. • To carry out necessary research work to meet requirements of the registration dossier. • To carry out large-scale trials to this purpose. • To address (e.g. by desk studies) likely concerns of registration authorities.

  3. Part A – Background (2)Key Stakeholders and Beneficiaries • Stakeholders and Beneficiaries:- • Donor: Technology Strategy Board • End-users: Grain producers, storers and processers • Partners: FERA; Exosect Ltd; Sylvan Spawn Ltd; Connaught. • CABI Centre: Europe-UK Theme - ISM

  4. Part B – Implementation (1)Proposed Organisation Structure • Corporate Management: Joan Kelley • Project Board:- • Project Executive: Julie Flood • Senior Users: Dick Shaw • Senior Suppliers: Sean Murphy • CABI Budget-holder: Sean MurphyNote that, if not the Project Executive, the CABI Budget-holder must have written confirmation from the Project Executive, and the Project Manager if required by Project Executive, prior to authorising payment. • Project Manager: Bryony Taylor • Team Managers: N/A

  5. Part B – Implementation (2)Stages

  6. Part B – Implementation (3)CABI Resource Requirements

  7. Part B – Implementation (4)Customer Acceptance Criteria The Technology Strategy Board accept that product registration is the objective, but that this objective will be abandoned if either the science or the market suggest that the product will not be successful. Abandonment will be an acceptable outcome.

  8. Part B – Implementation (5)Project Exclusions & Interfaces • Exclusions No commitment is made to registering a product if the scientific results prove unsatisfactory or if the financial returns are not considered acceptable. • Interfaces • The industrial partners determine the business profitability during the course of the project.

  9. Part B – Implementation (6)Key Constraints & Assumptions • Constraints • Limited budget. • Assumptions • Market parameters do not worsen • Timely release of funds • Partners cooperate and remain as functioning organisations • Do not lose skilled staff • Skilled staff are not deliberately removed from project

  10. Part C – Reasons for CABI (1)Key Business Benefits - Strategic • Expected £133,000 funding for three yr project • The project will result in a product for which CABI will gain considerable recognition (plus a royalty share). • There would be considerable opportunities to widen the use of the product, globally • The project will utilise biopesticide experience and help maintain this expertise within CABI • Strengthening of partnerships (FERA; a biocontrol company; user and producer) • Assist in further development of Beauveria based products.

  11. Part C – Reasons for CABI (2)Key Business Benefits – Financial(Externally funded Projects only)

  12. Part D – Risks (1)Key Risks(for Collaborator, Security, Technical Risks, see next slides)

  13. Part D – Risks (2)Collaborator Risks

  14. Part D – Risks (3)Security Risks

  15. Part D – Risks (4)Technical Risks

  16. Part E – Dissemination & Impact (1)Dissemination of Results

  17. Part E - Dissemination & Impact (2)Impact of Project(Scientific, Technical, Commercial, Social, Environmental)

  18. Part F – Reporting and Sign-off (1)Reporting

  19. Part F – Reporting & Sign-off (2)Supporting Documentation As a minimum to accompany the completed PID: • Project Financial Analysis Extra supporting documentation may be provided: • Gantt Chart (or Log Frame) • Any other documentation as appropriate Please note that projects with an Intellectual Property Right (IPR) component require the contract to be submitted to PMG prior to signature.

  20. Part F – Reporting & Sign-off (3)Authorisation • Project Executive / EMT: …………………………………………… • Date: ………………………………………………………….. • PMG Sign-off (Level 1 Projects) ………………………………………….. • Date: …………………………………………………………………………. • Approval of: • PID • Development of Business Plan • PMG Comments and/or Follow-on Actions:

  21. Appendix A – New Product / Initiative (1)

  22. Appendix A – New Product / Initiative (2)

More Related